Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments
2024

Comprehensive Review on Alzheimer's Disease and Tau Modifications

publication Evidence: moderate

Author Information

Author(s): Xin Li, Zhisheng Ba, Juan Huang, Jianhua Chen, Jinyu Jiang, Nanqu Huang, Yong Luo

Primary Institution: The Third Affiliated Hospital of Zunyi Medical University

Hypothesis

The review explores the role of posttranslational modifications of Tau in Alzheimer's disease and their potential as therapeutic targets.

Conclusion

Targeting specific posttranslational modifications of Tau may lead to novel therapeutic strategies for Alzheimer's disease.

Supporting Evidence

  • Tau aggregation is more closely associated with cognitive decline than Aβ in Alzheimer's disease.
  • Different types of posttranslational modifications have varying impacts on Tau's structure and function.
  • Current research is more extensive on phosphorylation, acetylation, ubiquitination, and methylation.
  • Drug development targeting Tau modifications is still in the early stages.

Takeaway

This study looks at how changes to a protein called Tau can cause problems in the brain for people with Alzheimer's, and suggests new ways to help treat it.

Methodology

The review summarizes existing research on the posttranslational modifications of Tau and their implications for drug development.

Limitations

The review highlights that most research is still in the basic research stage and clinical studies on PTM-regulated Tau are scarce.

Digital Object Identifier (DOI)

10.1002/ibra.12176

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication